Filing Details

Accession Number:
0000935836-23-000733
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-18 18:30:25
Reporting Period:
2023-09-12
Accepted Time:
2023-12-18 18:30:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750284 Olema Pharmaceuticals Inc. OLMA Pharmaceutical Preparations (2834) 300409740
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1777517 Walmsley G. Graham C/O Logos Global Management Lp
1 Letterman Drive, Bldg D, Ste D3-700
San Francisco CA 94129
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-12 508,130 $9.84 1,668,130 No 4 P Indirect See note
Common Stock Acquisiton 2023-12-05 31,870 $14.73 1,700,000 No 4 P Indirect See note
Common Stock Acquisiton 2023-12-05 50,000 $14.95 1,750,000 No 4 P Indirect See note
Common Stock Acquisiton 2023-12-05 50,000 $13.09 1,800,000 No 4 P Indirect See note
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See note
No 4 P Indirect See note
No 4 P Indirect See note
No 4 P Indirect See note
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,400,761 Indirect See note
Common Stock 1,183,114 Indirect See note
Footnotes
  1. The shares are held by Logos Global Master Fund LP ("Logos Master Fund"). Logos GP LLC ("Logos GP") is the general partner of Logos Master Fund and the reporting person is a managing member of Logos GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  2. The shares are held by Logos Opportunities Fund I LP ("Logos Fund I"). Logos Opportunities GP, LLC ("Logos Opportunities GP") is the general partner of Logos Fund I and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  3. The shares are held by Logos Opportunities Fund II LP ("Logos Fund II"). Logos Opportunities GP is the general partner of Logos Fund II and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.